SCHEMBL2804942

SCHEMBL2804942

C1CC[C](C2CC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9297274 0.96 KMT2A (0.32)
SCHEMBL1524586 0.96
SCHEMBL9297588 0.96 KMT2A (0.32)
SCHEMBL28469255 0.96 KMT2A (0.32)
SCHEMBL78897 0.92
SCHEMBL316141 0.89 CA1 (0.33)
SCHEMBL104445 0.89 CA1 (0.33)
SCHEMBL231283 0.89
SCHEMBL25327994 0.86 KMT2A (0.36)
SCHEMBL542776 0.86 KMT2A (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118063435-A Piperidine-2, 6-dione derivative and application thereof 西藏海思科制药有限公司 2024-05-24 CN claimed
CN-117720517-A AR inhibitor, composition thereof and pharmaceutical application thereof 西藏海思科制药有限公司 2024-03-19 CN claimed
WO-2023208165-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 四川海思科制药有限公司 2023-11-02 WO claimed
WO-2023151697-A1 METTL3 INHIBITOR AND COMPOSITION, AND APPLICATION OF SAME IN MEDICINE 四川海思科制药有限公司 2023-08-17 WO claimed
WO-2023143370-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND AS WELL AS COMPOSITION AND PHARMACEUTICAL USE THEREOF 四川海思科制药有限公司 2023-08-03 WO claimed
WO-2023143384-A1 COMPOUND FOR INHIBITING OR DEGRADING HPK1 KINASE AND MEDICAL USE THEREOF 四川海思科制药有限公司 2023-08-03 WO claimed
WO-2023131167-A1 COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 海思科医药集团股份有限公司 2023-07-13 WO claimed
WO-2023109902-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF IN MEDICINE 海思科医药集团股份有限公司 2023-06-22 WO claimed
WO-2023109892-A1 COMPOUND FOR INHIBITING OR DEGRADING BRD9, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF 海思科医药集团股份有限公司 2023-06-22 WO claimed
CN-115916747-A Fused heterocyclic derivative and application thereof in medicine 四川海思科制药有限公司 2023-04-04 CN claimed
WO-2016094489-A1 PHOSPHORUS LIGANDS AND METHODS OF USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-06-16 WO claimed
EP-1519928-B1 METHOD FOR PRODUCING HETEROCYCLIC FLUOROALKENYL SULFONES MAKHTESHIM CHEM WORKS LTD (IL) 2014-04-30 EP claimed
EP-0888337-B1 PIPERIDONE TACHYKININ ANTAGONISTS PFIZER RES & DEV (IE) 2002-06-05 EP claimed
US-6262075-B1 Piperidone tachykinin antagonists PFIZER INC 2001-07-17 US claimed
US-6096836-A OXYGEN CONTAINING AROMATIC CATALYST AND ALUMINUM COMPOUND KABUSHIKI KAISHA TOSHIBA (JP) 2000-08-01 US claimed
EP-0888337-A1 PIPERIDONE TACHYKININ ANTAGONISTS Pfizer Research and Development Company, N.V./S.A. (IE) 1999-01-07 EP claimed
WO-1997027185-A1 PIPERIDONE TACHYKININ ANTAGONISTS PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-07-31 WO claimed
US-5288733-A Quinolylmethoxyphenylacetic acid acylamides and ureas BAYER AKTIENGESELLSCHAFT (DE) 1994-02-22 US claimed
US-5210084-A Amidoalkylcarbamates BAYER AKTIENGESELLSCHAFT (DE) 1993-05-11 US claimed
CN-85105723-A Herbicidal compositions containing 1-aryl-4-substituted-1, 4-dihydro-5H-tetrazol-5-ones and their sulfur analogs 1986-05-10 CN claimed